NL-OMON36953撤回不适用
Safety and Efficacy of Embozene Microspheres for Uterine Fibroid Embolization compared to Embosphere for Symptomatic Relief from Uterine Fibroids - UFE FDA Celonova
Celonova0 个研究点目标入组 35 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •-Pre-menopausal women age 30-50 years at time of enrollment.
- •-Heavy menstrual bleeding with or without pain and bulk related symptoms
排除标准
- •Pregnant patient or intends to become.
- •Has HIV or other immunodeficient state
- •Already infarcted or calcified fibroids present.
- •Présence or suspicion of malignancy or infection
研究者
相似试验
Unknown
不适用
Safety and Efficacy of Embozene Microspheres for Uterine Fibroid EmbolizationUterine FibroidsNCT02884960Gary Siskin, MD118
终止
不适用
Embozene Microspheres for Uterine Fibroid Embolization (UFE)Uterine FibroidsNCT01675011Boston Scientific Corporation4
招募中
3 期
Investigating the effect of empagliflozin in heart failure in HIV patientsIRCT20130719014054N2Tehran University of Medical Sciences128
招募中
1 期
Investigating the safety and efficacy of stem cell exosomes on diabetic foot ulcersDiabetic Foot Ulcer.Type 2 diabetes mellitusIRCT20240317061316N1Qazvin University of Medical Sciences40
尚未招募
不适用
Comparison of Dermaroller versus Dermaroller with topical PRP versus glycolic acid chemical peels in melasmaCTRI/2021/03/031705Dr Surabhi Dayal